Urgent.News

What's breaking now, across thousands of outlets.

Health & Medicine

Cipla inks partnership with China’s Qilu Pharma for cancer biosimilar

The partnership reflects Cipla’s confidence in the long-term potential of biosimilars and supports its strategy to build a strong oncology-focused portfolio.

Cipla inks partnership with China’s Qilu Pharma for cancer biosimilar

We haven't written up this one. The Hindu Health has the full story — the link below goes straight to it.

Also reported by 1 other outlet

Read the original at thehindu.com →

More in Health & Medicine

How to Keep Children Safe from Wildfire Smoke

Children are among the most vulnerable to health risks due to wildfire smoke exposure. Check out some of the advice to keep them safe from haze.

  • Over 50,000 respiratory infections reported in Indonesia July-August.
  • Children under five affected by 12,000 respiratory infections.
  • UNICEF advises explaining risks to children in age-appropriate manner.

More from Saturday 5 September →